MENU

Statement of the DDB on the change of leadership in the Philippine Drug Enforcement Agency

The Dangerous Drugs Board welcomes the assumption of new PDEA Director General Wilkins Villanueva after Malacañang released his appointment signed last 22 May 2020. Incoming DG Villanueva has been a steadfast partner of DDB even during his early years as career officer of PDEA. DDB has involved him in many of its anti-drug efforts particularly in policy formulation and strategy development aspects which helped craft many of its inter-agency priorities all these years. Recognizing him as the 7th Director-General of PDEA, DDB intends to engage more closely and deepen the collaboration with his leadership noting that he will become an Ex-Officio Member of the Board.

Read more ...

DDB Eases the Use of Prescription Forms for Dangerous Drugs

The Dangerous Drugs Board now allows the use of ordinary prescription for medical preparations containing dangerous drugs.

Read more ...

DDB advocates for the use of electronic prescription for dangerous drugs medication

The Dangerous Drugs Board appeals to doctors, pharmacists, and drug store personnel to consider the use of electronic prescription for medicines included in the list of dangerous drugs as the whole country is under a State of Calamity due to the COVID-19 pandemic.

Read more ...

DDB, SDA Church hold program to update health directors on the Philippine Anti-Illegal Drugs Strategy (PADS) and board regulations

The Dangerous Drugs Board, in collaboration with the Southern Asia-Pacific Division of the Seventh-Day Adventist Church, convenes Luzon-based health directors of the religious group to update them on the Philippine Anti-Illegal Drugs Strategy (PADS) and relevant DDB regulations.

Read more ...

DDB clarifies: CBD is not cannabis per se

The Dangerous Drugs Board would like to clarify that marijuana use remains illegal in the country for both recreational and medical use. The use of Cannabidiol, however, is being considered to be allowed for treatment of certain rare forms of epilepsy like Lennox-Gastaut and Dravet Syndrome.

Read more ...

DDB, DOST-FNRI launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

DDB, DOST-FNRI to launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, will officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

PRRD reappoints Cuy as Chairperson of DDB

Secretary Catalino S. Cuy was given a fresh mandate as the Chairperson of the Dangerous Drugs Board (DDB).

This was confirmed after President Rodrigo Duterte signed his reappointment papers on 21 January 2020. Secretary Cuy was first appointed at the DDB in January 2018 serving the remainder of the term of his predecessor.

Read more ...

DDB’s response to the recommendations of the Vice President on the campaign against illegal drugs

The Dangerous Drugs Board notes the recommendations of Vice President Leni Robredo on the anti-drug campaign. The agency keeps in mind the ultimate goal of establishing drug-free communities as a serious commitment of the Duterte Administration.

Read more ...

PROFILE OF DRUG ABUSERS
(Facility based)
CY 2008

AGE : Mean age of 28 years
SEX : Ratio of male to female 9:1
CIVIL STATUS : Single
OCCUPATION : Unemployed
EDUCATIONAL ATTAINMENT : High School
ECONOMIC STATUS:Average monthly family income P15,064.72
PLACE OF RESIDENCE : Urban (specifically NCR)
DURATION OF DRUG TAKING : More than six (6) years
NATURE OF DRUG – TAKING : Poly drug use**
DRUGS OF ABUSE : Methamphetamine Hydrochloride (Shabu)
                                 Cannabis (Marijuana)
                                 Inhalants (Contact Cement Adhesive)

*Residential and Out-Patient Facilities

**Poly drug users -  abuse of more than one (1) drug

 

PROFILE OF DRUG DEPENDENTS

There were more male than female drug users with ratio of 9:1.  The youngest admitted case was aged 9 and the oldest, 70.  Majority were between 25 and 29 pegging the average age of drug dependents under rehabilitation at 28 years old.

Patients confessed of first experimenting on drugs at 15 to 19 years old, pointing to their peers as their primary source of illicit substance.  Regular pushers were relegated to secondary spot.

With regard to civil status, 57.23% were single; 25.16%, married; and 10.58%, with live-in partners.

As to occupational status, 33.92% were unemployed; 20.02%, workers; 9.78%, self-employed; and 9.27%, students.

Nearly 32% reached high school while 25.18%, college level.  Their average monthly family income was ₱15,064.72.

 

REPORTED CASES BY GENDER
(Facility - Based)
CY 2008

                                                   MALE             FEMALE       GRAND TOTAL
TYPE OF ADMISSION NO. % NO. % NO. %
NEW ADMISSIONS 1,951 55.33 246 6.98 2,197 62.31
READMISSIONS 526 14.92 38 1.08 564 16.00
OUT - PATIENT 689 19.54 76 2.16 765 21.70
T O T A L 3,166 89.79 360 10.21 3,526 100.00

* Total Reported Cases from Residential and Out-Patient Facilities

 

DRUG TREATMENT AND REHABILTATION ADMISSIONS

Drug abusers come from all walks of life, from different ages and from varied social backgrounds.  In 2008, a total of 3,526 clients were admitted from both the residential and out-patient facilities nationwide.  Of this, 62% or 2,197 were new admissions, 16% or 564 were relapse or readmitted cases, and 22% or 765 were referrals from the out-patient centers.

The National Capital Region (NCR) showed the highest percent distribution of cases with 1,964 or 55.70% of the total admission nationwide.  Region IV-A (CALABARZON) and Region III (Central Luzon) followed with 14.49% and 13.90% admission percentage respectively.

 

MOST COMMONLY USED/ABUSED DRUGS/SUBSTANCES
(Facility Based)
CY 2008

DRUGS USED / ABUSED NEW ADMISSIONS RE-ADMISSIONS OUT-PATIENT GRAND TOTAL % based on the total number of responses (4,751) % based on the total number of admissions (3,526)
1. Methamphetamine Hydrochloride(Shabu) 1,534 480 394 2,408 50.68 68.29
2. Cannabis (Marijuana) 1,020 244 436 1,700 35.78 48.21
3. Inhalants (Contact Cement Ex.: Rugby) 146 31 126 306 6.44 8.68
4. Benzodiazepines 92 21 6 119 2.50 3.37
5. Nalbuphine Hydrochloride (Nubain) 48 5   53 1.12 1.50
6. Cocaine 38 9 2 49 1.03 1.39
7. Cough / Cold Preparations 35 8   43 0.91 1.22
8. MDMA (Ecstasy) 27 9 1 37 0.78 1.05
9. Ketamine 10 1   11 0.23 0.31
10. Solvent 6 2 1 9 0.19 0.26

* Total Reported Cases from Residential and Out-Patient Facilities

 

Methamphetamine hydrochloride commonly known as “shabu” remained as the top drug of abuse with 2,408 cases (68.29%), followed by cannabis or marijuana with 1,700 (48.21%), and contact cement at 8.93% of the entire patient population.  The nature of drug taking was poly-drug use while the routes of administration were inhalation/sniffing and oral ingestion.

 

Admitted cases were down by 18% in 2008.  The decline may be attributed to:  1) financial constraints that confront families of drug users, 2) closure of some rehabilitation centers due to change in administration and some minor deficiencies that prevented them to operate, or sustain the operation, 3) stringent requirements for accreditation of centers by the Department of Health, 4) denial on the part of the family of drug dependents, and 5) relentless efforts of the government to eradicate the drug abuse problem.  This can be supported by the data on the increase of drugs seized and clandestine laboratories dismantled during the year.